Neurociencias
Mayo Clinic
Rochester, Estados UnidosPublicacións en colaboración con investigadores/as de Mayo Clinic (5)
2019
-
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Acta Neuropathologica, Vol. 138, Núm. 2, pp. 237-250
2018
-
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study
The Lancet Neurology, Vol. 17, Núm. 6, pp. 548-558
2015
-
Clinical correlations with lewy body pathology in LRRK2-related Parkinson disease
JAMA Neurology, Vol. 72, Núm. 1, pp. 100-105
2010
-
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions
Nature Genetics, Vol. 42, Núm. 3, pp. 234-239